文献速递皮肤肿瘤

1989-2013年荷兰儿童与青少年黑色素瘤发病率及相对生存率

Incidence and relative survival of melanoma in children and adolescents in the Netherlands, 1989-2013.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-11-28

基于荷兰癌症登记处1989-2013年数据,纳入0-19岁经组织学确诊的皮肤侵袭性黑色素瘤患者80例儿童和544例青少年。青少年(12-19岁)发病率1991年起每年增3.2%(95%CI 1.3-5.1),2005-2013年每年降4.9%(95%CI -9.6-0.0);儿童无趋势。1、5、10年相对生存率分别为98%、94%、90%,男性及Breslow厚度更高者生存更差。

要点

  • 12岁以下儿童黑色素瘤罕见且发病率稳定(APC 0.3%,95%CI -3.0-3.8)。
  • 青少年发病率1991-2005年上升(APC 3.2%),2005-2013年下降(APC -4.9%)。
  • 1、5、10年相对生存率分别为98%、94%、90%,男性及Breslow厚度高者生存更差。

核心结论

  • 12岁以下儿童黑色素瘤非常罕见且发病率稳定。
  • 青少年黑色素瘤更常见,但过去十年发病率呈下降趋势。
  • 男性及Breslow厚度增加与儿童青少年黑色素瘤生存更差相关。

研究设计与样本

  • 基于荷兰癌症登记处(NCR)1989-2013年数据,纳入0-19岁经组织学确诊的皮肤侵袭性黑色素瘤患者。
  • 共登记80例儿童(0-11岁)和544例青少年(12-19岁)。
  • 采用Joinpoint回归分析发病率趋势,并进行相对生存分析。

主要发现

  • 诊断中位年龄17岁(IQR 15-18),女性与男性比为1.7:1。
  • 青少年(12-19岁)发病率1991年起每年增3.2%(95%CI 1.3-5.1),2005-2013年每年降4.9%(95%CI -9.6-0.0)。
  • 儿童(0-11岁)发病率无显著趋势(APC 0.3%,95%CI -3.0-3.8)。
  • 1、5、10年相对生存率分别为98%(95%CI 97-99)、94%(95%CI 92-96)、90%(95%CI 87-92)。
  • 男性及Breslow厚度更高者生存更差。

临床怎么用

  • 对青少年黑色素瘤应保持警惕,尽管近十年发病率下降。
  • 儿童黑色素瘤罕见,发病率稳定,但男性及Breslow厚度高者需关注预后。
  • 生存数据可用于患者及家属预后沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanoma is rare in the first two decades of life. Trends in incidence differ across countries. OBJECTIVE: To describe incidence and relative survival of children and adolescents with melanoma in the Netherlands for children (0 through 11 years) and adolescents (12 through 19 years) separately. We hypothesized that adolescent melanoma increased in contrast to childhood melanoma, possibly due to a difference in cancer biology and sun exposure patterns. METHODS: Data on all patients of 0-19 years diagnosed between 1989 and 2013 with histologically confirmed cutaneous invasive melanoma were retrieved from the Netherlands Cancer Registry (NCR). Incidence trends were analysed with Joinpoint regression. Relative survival analysis was performed. RESULTS: Between 1989 and 2013, 80 children and 544 adolescents with melanoma were registered in the NCR. Median age at diagnosis was 17 years (IQR 15-18); the female-to-male ratio was 1.7 : 1 Statistically significant incidence trends were found in the older age group (12-19 years): an increasing incidence since 1991 [annual percentage change (APC) 3.2%, 95%CI 1.3-5.1] followed by a decrease from 2005 to 2013 (APC -4.9%, 95%CI -9.6-0.0). No incidence trends for childhood melanoma were observed (APC 0.3%, 95% CI -3.0-3.8). Relative survival at 1, 5 and 10 years was 98% (95% CI 97-99), 94% (95% CI 92-96) and 90% (95% CI 87-92), respectively. Survival was worse in males and higher Breslow thickness. CONCLUSIONS: Melanoma is very rare under the age of 12 with stable incidence rates. In comparison with childhood melanoma, melanomas in adolescents are more common with a decreasing trend in the past decade. Male sex and increasing Breslow thickness are associated with worse survival in paediatric melanoma patients.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Eggen CAM, Durgaram VVL, van Doorn R, et al. Incidence and relative survival of melanoma in children and adolescents in the Netherlands, 1989-2013. J Eur Acad Dermatol Venereol. 2017. PMID: 29080310. doi:10.1111/jdv.14665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。